Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells-Reference-Cited by-同舟云学术

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells

Published:2021-06 Issue: Volume:21 Page:42-53
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Cordes Nicole,Kolbe Carolin,Lock Dominik,Holzer Tatjana,Althoff Deborah,Schäfer Daniel,Blaeschke Franziska,Kotter Bettina,Karitzky Sandra,Rossig Claudia,Cathomen Toni,Feuchtinger Tobias,Bürger Iris,Assenmacher Mario,Schaser Thomas^ORCID,Kaiser Andrew D.

Funder

H2020

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference41 articles.

1. Mechanisms of resistance to CAR T cell therapy;Shah;Nat. Rev. Clin. Oncol.,2019

2. Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell;Ruella;Nat. Med.,2018

3. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

4. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

5. Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors;Johnson;Biologicals,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early induction of cytokine release syndrome by rapidly generated CAR T cells in preclinical models;EMBO Molecular Medicine;2024-03-21

2. Universal ddPCR-based assay for the determination of lentivirus infectious titer and lenti-modified cell vector copy number;Molecular Therapy - Methods & Clinical Development;2023-12

3. CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes;Frontiers in Immunology;2023-08-14

4. Early induction of cytokine release syndrome by rapidly generated CAR T cells in a preclinical mouse model;2022-11-12

5. Current updates on generations, approvals, and clinical trials of CAR T-cell therapy;Human Vaccines & Immunotherapeutics;2022-09-12